Regeneron Pharmaceuticals Inc at Evercore ISI Healthcare Conference Transcript
Good afternoon, everybody. My name is Cory Kasimov, one of the senior biotech analysts here at Evercore ISI. And it's my pleasure to host our next discussion with Regeneron. We're fortunate to have both Marion McCourt, who heads up Commercial; as well as Ryan Crowe, SVP of IR and Strategic Analysis. And we have them for a full 45 minutes, which I'm sure you guys are thrilled about.
In all seriousness, thank you both very much for being here today. And Ryan, I guess let me hand it over to you first, read off your little thing, and then we'll get going.
I'll read my little thing. But first, I will say thank you, Cory, and to Evercore for having us here. Great conference, as always, and a lot of great meetings so far. So excited to do this fireside chat with you, even though it is an extended version of a typical fireside chat.
But without further ado, I would like to remind you that remarks made
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
